A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
Bayer
Bayer
Medical University of South Carolina
National Cancer Institute (NCI)
INSYS Therapeutics Inc
East and North Hertfordshire NHS Trust